ArticleCancer medicine2023

An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.

Du Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.